D-0537-2023 Class II Ongoing

Recalled by Pharma Nobis LLC — Texarkana, TX

FDA drug recall D-0537-2023 was initiated by Pharma Nobis LLC on Apr 6, 2023 and is designated Class II. Reason for recall: CGMP Deviations: active ingredient may be subpotent before the labeled expiry due to degradation. The recall status is ongoing. Affected quantity: 69,615 bottles.

Recall Details

Product Type
Drugs
Report Date
Apr 26, 2023
Initiation Date
Apr 6, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
69,615 bottles

Product Description

Fast Acting Earwax Removal System (carbamide peroxide), 6.5%, 0.5 FL OZ (15 mL) Drops per bottle, OTC, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, CVS Product # 999532, UPC 0 50428 36475 8.

Reason for Recall

CGMP Deviations: active ingredient may be subpotent before the labeled expiry due to degradation.

Distribution Pattern

Nationwide in the USA

Code Information

Lots: A70293, A70294, A70295, Exp. 12/2023; A70746, A70747, A70748, A70749, Exp. 01/2024; A73051, A73052, Exp. 05/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0537-2023
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0537-2023. Report a data issue: hello@regdatalab.com.